United States · FDA National Drug Code directory
Lisinopril
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43547-415_1ed80b02-cb3b-41c5-ab33-ff0106b8792d
- Product NDC
- 43547-415
- Form
- TABLET
- Composition / generic term
- Lisinopril
- Labeler
- Solco healthcare U.S., LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170830
- Source listing expiry
- 20261231
Source-listed ingredients
- LISINOPRIL — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (43547-415-03) · 43547-415-03
- 45 TABLET in 1 BOTTLE (43547-415-04) · 43547-415-04
- 90 TABLET in 1 BOTTLE (43547-415-09) · 43547-415-09
- 100 TABLET in 1 BOTTLE (43547-415-10) · 43547-415-10
- 1000 TABLET in 1 BOTTLE (43547-415-11) · 43547-415-11
- 2500 TABLET in 1 BOTTLE (43547-415-25) · 43547-415-25
- 500 TABLET in 1 BOTTLE (43547-415-50) · 43547-415-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →